- Trials with a EudraCT protocol (3,872)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (130)
3,872 result(s) found for: Product.
Displaying page 4 of 194.
| EudraCT Number: 2005-001133-15 | Sponsor Protocol Number: 19.4.208B | Start Date*: 2005-09-08 |
| Sponsor Name:NV Organon | ||
| Full Title: A multi-center, randomized, open-label, prospective bridging, parallel dosefinding trial comparing efficacy, safety and pharmacokinetics of 4 doses of Org 25969 and placebo administered at reappear... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) BE (Completed) DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-007951-14 | Sponsor Protocol Number: 19.4.318 | Start Date*: 2008-05-05 |
| Sponsor Name:NV Organon | ||
| Full Title: A multi-center, randomized, parallel-group, comparative, active-controlled, safety-assessor blinded trial in adult subjects comparing the efficacy and safety of sugammadex administered at 1-2 PTC w... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) GB (Completed) DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-005649-12 | Sponsor Protocol Number: SUCPAT1_CTR0026 | Start Date*: 2006-12-20 |
| Sponsor Name:Regent Medical | ||
| Full Title: A 96 hour (4-application) patch test and TEWL assessment in healthy volunteers to investigate the comparative skin irritation potential of six antiseptics and two controls following cutaneous patch... | ||
| Medical condition: This trial will be carried out on healthy volunteers. Patches containing 0.2mls of each test product will be used. Each volunteer will have a single patch per product and the patches will be remov... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-024449-65 | Sponsor Protocol Number: 159:2010/526806 | Start Date*: 2011-02-22 | |||||||||||
| Sponsor Name:Västerbottens läns landsting | |||||||||||||
| Full Title: Will there be lipid changes during dialysis with Citrasate as dialysate compared to conventional dialysis. | |||||||||||||
| Medical condition: Chronic haemodialysis patients 18 years upwards. Patients should be in a stable condition during their chronic dialysis program (no ongoing infections or active extensive tumour with CRP above 30 m... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-001134-32 | Sponsor Protocol Number: 19.4.209B | Start Date*: 2005-08-18 |
| Sponsor Name:NV Organon | ||
| Full Title: A multi-center, randomized, open-label, prospective bridging, parallel dosefinding trial comparing efficacy and safety of 5 doses of Org 25969 administered at 1-2 PTC after rocuronium or vecuronium... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-001570-29 | Sponsor Protocol Number: NL4014200012 | Start Date*: 2012-08-28 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT) for focal articular cartilage lesions of the knee; feasibility and safety | ||
| Medical condition: Articular cartilage defects of the femural condyl and trochlea of the knee | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-000814-11 | Sponsor Protocol Number: HHT-CML/INTL/04.3 | Start Date*: 2005-10-19 |
| Sponsor Name:STRAGEN France [...] | ||
| Full Title: A phase II, multicentre, open-label, single arm, extension study of maintenance treatment with subcutaneous homoharringtonine (HHT) as a single agent in patients with chronic myeloid leukemia (CML)... | ||
| Medical condition: Chronic myeloid leukemia (CML) | ||
| Disease: | ||
| Population Age: Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-004084-37 | Sponsor Protocol Number: CT214 | Start Date*: 2005-11-11 |
| Sponsor Name:SSL International plc | ||
| Full Title: A phase III, randomised, controlled, assessor-blind, parallel group clinical trial to confirm the safety and efficacy of an experimental pediculicide rinse and Lyclear Creme Rinse in the treatment ... | ||
| Medical condition: Head lice infestation | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-005821-31 | Sponsor Protocol Number: GA0706 | Start Date*: 2008-01-15 |
| Sponsor Name:Reckitt Benckiser Healthcare UK) Limited [...] | ||
| Full Title: A single-centre randomised, partially blind, single dose, crossover pilot study investigating the use of stopwatches to assess the onset of action of soothing and cooling of Gaviscon Peppermint Liq... | ||
| Medical condition: Symptoms of heartburn | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-005268-13 | Sponsor Protocol Number: BAYH6689/13129 | Start Date*: 2015-02-05 |
| Sponsor Name:Bayer HealthCare AG | ||
| Full Title: An Open Label, Actual Use Study in Consumers Taking an Extended-Release Over the Counter NSAID in a Naturalistic Setting | ||
| Medical condition: Pain | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2014-003401-15 | Sponsor Protocol Number: D2560C00007 | Start Date*: 2015-03-24 |
| Sponsor Name:AstraZeneca K.K. | ||
| Full Title: A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children age 2 years through 6 years | ||
| Medical condition: Healthy Children | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2011-002755-34 | Sponsor Protocol Number: SWB-06-11 | Start Date*: 2012-02-22 |
| Sponsor Name:Serumwerk Bernburg AG | ||
| Full Title: Open clinical study to determine the compatibility of Pyolysin®-Salbe in children aged between 0 and 17 years during the dermatological treatment of superficial wounds | ||
| Medical condition: Superficial wounds in children aged between 0 and 17 years such as wounds caused by scraping, abrasions, bagatell injuries | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-000813-36 | Sponsor Protocol Number: HHT-CML/INTL/04.2 | Start Date*: 2005-10-14 |
| Sponsor Name:STRAGEN France [...] | ||
| Full Title: A phase II, multicentre, single-arm, open-label study of subcutaneous homoharringtonine (HHT) alone in patients with accelerated phase chronic myeloid leukemia (CML) who are refractory to, or have ... | ||
| Medical condition: Accelerated phase Chronic Myeloid Leukaemia (CML). | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-003555-11 | Sponsor Protocol Number: PD20180302 | Start Date*: 2021-04-19 |
| Sponsor Name:ASSISTANCE PUBLIQUE-HOPÏTAUX DE PARIS | ||
| Full Title: A Phase 1/2 Open Label non randomized Study, multicentric, single arm evaluating the Safety and Efficacy of Gene Therapy of the severe combined immunodeficiency (SCID) caused by mutations in the ... | ||
| Medical condition: immunodeficiency (SCID) caused by mutations in the human DCLRE1C gene (Artemis) | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-000434-34 | Sponsor Protocol Number: HEM-01-17 | Start Date*: 2020-06-18 | |||||||||||
| Sponsor Name:Sealantium Medical Ltd. | |||||||||||||
| Full Title: A Phase I/II, randomized, prospective, controlled, multi-center, open-label, two arm study evaluating the safety and preliminary efficacy of sFilm-FS in controlling liver bleeding during elective s... | |||||||||||||
| Medical condition: Open hepatic surgery, with presence of an target bleeding site (TBS). | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SI (Completed) AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-003186-18 | Sponsor Protocol Number: LOWOL-19 | Start Date*: 2020-02-05 |
| Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | ||
| Full Title: EFICACY AND TOLERABILITY OF TWO REDUCED VOLUME PRODUCTS FOR COLORRECTAL CANCER SCREENING COLONOSCOPY: A COMPARATIVE, PARALLEL RANDOMIZED CLINICAL TRIAL. LOWOL STUDY. | ||
| Medical condition: compare the adenoma detection rate between the two products | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-000946-69 | Sponsor Protocol Number: AZ07 | Start Date*: 2016-07-05 | ||||||||||||||||
| Sponsor Name:AZAD Pharma AG | ||||||||||||||||||
| Full Title: A PHASE III, MULTICENTRE, RANDOMISED, INVESTIGATOR-MASKED, CROSS- OVER, COMPARATIVE CLINICAL TRIAL EVALUATING THE EFFICACY AND SAFETY OF THE GENERIC BRINZOLAMIDE 10 MG/ML + TIMOLOL 5 MG/ML EYE DROP... | ||||||||||||||||||
| Medical condition: Decrease of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: HU (Completed) AT (Completed) PL (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2010-023803-92 | Sponsor Protocol Number: NN1731-3562 | Start Date*: 2011-06-01 | ||||||||||||||||
| Sponsor Name:Novo Nordisk A/S | ||||||||||||||||||
| Full Title: Efficacy and Safety of NNC 0078-0000-0007 in Treatment of Acute Bleeding Episodes in Patients with Congenital Haemophilia and Inhibitors | ||||||||||||||||||
| Medical condition: Congenital Haemophilia and Inhibitors | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male | |||||||||||||||||
| Trial protocol: GB (Completed) AT (Completed) GR (Completed) PL (Completed) ES (Prematurely Ended) IT (Completed) HU (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2009-016629-33 | Sponsor Protocol Number: H521000-0914 | Start Date*: 2009-12-22 | |||||||||||
| Sponsor Name:Almirall Hermal GmbH | |||||||||||||
| Full Title: A 12 day placebo- and reference-controlled, double-blind, single center, randomized, phase II clinical study with an intraindividual comparison, investigating the anti-psoriatic efficacy and the to... | |||||||||||||
| Medical condition: Psoriasis vulgaris | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-000991-34 | Sponsor Protocol Number: DMP 81.1.05 | Start Date*: 2006-04-21 |
| Sponsor Name:Dr. Gerhard Mann, Chem-pharm. Fabrik GmbH | ||
| Full Title: A randomized, double-blind, monocentric phase IV clinical study on the ocular tolerability of a topical ophthalmic product containing Retinolpalmitat 1000 I.U. in comparison to a reference product ... | ||
| Medical condition: Patients suffering from keratoconjunctivitis sicca (dry eye) and break-up-time (BUT) values < 10 sec | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
